Cannabinoid CB1 receptor antagonism modulates plasma corticosterone in rodents

European Journal of Pharmacology

Volumn 551, Issue 1-3, 2006, Pages 162-167

  Wade, Mark R ^a   Degroot, Aldemar ^a   Nomikos, George G ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Cannabinoid; CB1 receptor; Corticosterone; Plasma; Rodent

Indexed keywords

CANNABINOID 1 RECEPTOR; CORTICOSTERONE; RIMONABANT; BIOLOGICAL MARKER; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG MECHANISM; DRUG RESPONSE; KNOCKOUT MOUSE; MALE; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; WILD TYPE; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECT; DRUG MONITORING; DRUG SCREENING; GENETICS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; METHODOLOGY; MOUSE MUTANT; REPRODUCIBILITY; TIME; WISTAR RAT;

ANIMALS; BIOLOGICAL MARKERS; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; DRUG MONITORING; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PIPERIDINES; PITUITARY-ADRENAL SYSTEM; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 33748921976     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.08.083     Document Type: Article

References (27)

1. Barna I., Zelena D., Arszovszki A.C., and Ledant C. The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1R receptor knockout mice. Life Sci. 75 (2004) 2959-2970
2. Columbo G., Agabio R., Diaz G., Lobina C., Reali R., and Gessa G.L. Appetite suppression and weight loss after the cannabinoid receptor antagonist SR141716A. Life Sci. 63 (1998) 113-117
3. Degroot A., and Nomikos G.G. Genetic deletion and pharmacological blockade of CB1R receptors modulates anxiety in the shock-probe burying test. Eur. J. Neurosci. 20 (2004) 1059-1064
4. Deroche-Gamonet V., Le Moal M., Piazza P.V., and Soubrie P. SR141716, a CB1R receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats. Psychopharmacology 157 (2001) 254-259
5. Devane W.A., Dysfarz F.A., Johnson M.R., Melvin L.S., and Hewlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34 (1988) 605-613
6. Di S., Malcher-Lopes R., Halmos K.C., and Tasker J.G. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J. Neurosci. 23 (2003) 4857-4857
7. Di Marzo V., Breivogel C.S., Tao Q., Bridgen D.T., Razdan R.K., Zimmer A.M., Zimmer A., and Martin B.R. Levels, metabolism, and pharmacological activity of anandamide in CB1R cannabinoid receptor knockout mice: evidence for non-CB1R, non-CB2 receptor-mediated actions of anandamide in mouse brain. J. Neurochem. 75 (2000) 2434-2444
8. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jaral Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., and Kunos G. Leptin regulated endocannabinoids are involved in maintaining food intake. Nature 410 (2001) 822-825
9. 9-tetrahydrocannabinoid-tolerent rats: an experimental model of abstinence. Drug Alcohol Depend. 74 (2004) 159-270
10. Haller J., Bakos N., Szirmay M., Ledent C., and Freund T.F. The effects of genetic and pharmacological blockade of the CB1R cannabinoid receptor on anxiety. Eur. J. Neurosci. 16 (2002) 1395-1398
11. Harris R.B.S., Gu H., Mitchell T.D., Endale L., Russo M., and Ryan D.H. Increased glucocorticoid response to a novel stress in rats that have been restrained. Physiol. Behav. 81 (2004) 557-568
12. Huestis M.A., Gorelick D.A., Heishman S.J., Preston K.L., Nelson R.A., Moolchan E.T., and Frank R.A. Blockade of effects of smoked marijuana by the CB1R-selective cannabinoid receptor antagonist SR141716. Arch. Gen. Psychiatry 58 (2001) 322-328
13. Köfalvi A., Rodrigues R.J., Ledent C., Mackie K., Vizi E.S., Cunha R.A., and Sperlágh B. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. J. Neurosci. 25 (2005) 2874-2884
14. Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Belost F., Bohme G.A., Imperato A., Pedrazzini T., Roques B.P., Vassart G., Fratta W., and Parmentier M. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283 (1999) 401-404
15. Manzanares J., Corchero S., and Fuentes J.A. Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotrophin hormone and corticosterone plasma concentrations induced by central administration of delta-9-tetrahydrocannabinol in rats. Brain Res. 839 (1999) 173-179
16. Murphy L.L., Muñoz R.M., Adrian B.A., and Villanúa M.A. Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiol. Dis. 5 (1998) 432-446
17. Patel S., Roelke C.T., Rademacher D.J., Cullinan W.E., and Hillard C.J. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 145 (2004) 5431-5438
18. Pistis M., Perra S., Pillolla G., Melis M., Muntoni A.L., and Gessa G.L. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biol. Psychiatry 15 (2004) 86-94
19. 1-tertahydrocannabinol, in intact and in hypothalamic deafferentated male rats. Exp. Brain Res. 46 (1982) 85-88
20. Rodríguez de Fonseca F., Carrea M.R.A., Navarro M., Koob G.F., and Weiss F. Activation of corticotrophin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276 (1997) 2050-2053
21. Steger R.W., Murphy L.L., Bartke A., and Smith W.S. Effects of psychoactive and nonpsychoactive cannabinoids on the hypothalamic-pituitary axis of the adult male rat. Pharmacol. Biochem. Behav. 37 (1990) 299-302
22. Tzavara E.T., Davis R.J., Perry K.W., Li X., Salhoff C., Bymaster F.P., Witkin J.M., and Nomikos G.G. The CB1R receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br. J. Pharmacol. 138 (2003) 544-553
23. Tzavara E.T., Wade M.R., and Nomikos G.G. Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action. J. Neurosci. 23 (2003) 9374-9384
24. Urigüen L., Pérez-Rial S., Ledent C., Palomo T., and Manzanares J. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1R receptors. Neuropharmacology 46 (2004) 966-973
25. Weidenfeld J., Feldman S., and Mechoulam R. Effect of the brain constituent anadamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat. Neuroendocrinology 59 (1994) 110-112
26. Wenger T., Ledent C., and Tramu G. The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1R cannabinoid receptor knockout mice. Neuroendocrinology 78 (2003) 294-300
27. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., and Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1R receptor knockout mice. Proc. Natl. Acad. Sci. 96 (1999) 5780-5785